These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25617528)

  • 1. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.
    Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R
    Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
    Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
    Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
    Patel R; Shervington L; Lea R; Shervington A
    Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.
    Chu SH; Feng DF; Ma YB; Zhang H; Zhu ZA; Li ZQ; Jiang PC
    J Transl Med; 2011 Sep; 9():156. PubMed ID: 21936894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
    Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.
    Liu DM; Wang HJ; Han B; Meng XQ; Chen MH; Yang DB; Sun Y; Li YL; Jiang CL
    CNS Neurosci Ther; 2016 Jun; 22(6):518-24. PubMed ID: 27012733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors.
    Horiguchi K; Tomizawa Y; Tosaka M; Ishiuchi S; Kurihara H; Mori M; Saito N
    Oncogene; 2003 Oct; 22(49):7862-5. PubMed ID: 14586413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
    Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
    Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 promoter methylation in human gliomas.
    Amatya VJ; Naumann U; Weller M; Ohgaki H
    Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
    Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
    Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells.
    Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA
    Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.
    Zhou Y; Jin G; Mi R; Dong C; Zhang J; Liu F
    Brain Res; 2014 Mar; 1556():57-66. PubMed ID: 24502980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.